Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7299
    -0.0021 (-0.29%)
     

  • CRUDE OIL

    82.84
    -0.52 (-0.62%)
     

  • Bitcoin CAD

    88,062.23
    -3,020.41 (-3.32%)
     

  • CMC Crypto 200

    1,385.35
    -38.75 (-2.72%)
     

  • GOLD FUTURES

    2,328.90
    -13.20 (-0.56%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,507.25
    -99.50 (-0.57%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6821
    -0.0015 (-0.22%)
     

VIVUS Announces Date of 2017 First Quarter Business Update and Financial Results Teleconference

Marketwired

CAMPBELL, CA--(Marketwired - April 25, 2017) - VIVUS, Inc. (VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2017 after the NASDAQ Market closes on Wednesday, May 3, 2017. The company will conduct a conference call and an audio webcast at 4:30 pm ET the same day.

Date: May 3, 2017
Time: 4:30 PM ET

Listen via Internet: http://ir.vivus.com/

Webcast Link: http://edge.media-server.com/m/p/76esnfqz

Dial in (Toll-Free): (877) 359-2916
Dial in (International): (224) 357-2386
Audience Passcode: 938 46 816

A webcast replay will be available on the VIVUS website for 30 days.

ADVERTISEMENT

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet medical needs in human health. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ended December 31, 2016 as filed on March 8, 2017 and periodic reports filed with the Securities and Exchange Commission.